- Report
- July 2025
- 131 Pages
Japan
From €4904EUR$5,550USD£4,321GBP
- Report
- July 2025
- 90 Pages
Japan
From €4904EUR$5,550USD£4,321GBP
- Report
- June 2025
- 75 Pages
From €3049EUR$3,450USD£2,686GBP
- Report
- April 2025
- 227 Pages
China
From €3535EUR$4,000USD£3,114GBP
- Report
- April 2025
- 114 Pages
China
From €1591EUR$1,800USD£1,401GBP
- Report
- April 2025
- 61 Pages
China
From €1591EUR$1,800USD£1,401GBP
- Report
- March 2025
- 74 Pages
China
From €1591EUR$1,800USD£1,401GBP
- Report
- March 2025
- 111 Pages
China
From €1591EUR$1,800USD£1,401GBP
- Report
- December 2024
- 505 Pages
Global
From €3535EUR$4,000USD£3,114GBP
- Report
- September 2024
- 72 Pages
Global
From €3535EUR$4,000USD£3,114GBP
- Report
- August 2024
- 83 Pages
Global
From €3535EUR$4,000USD£3,114GBP
- Report
- June 2024
- 200 Pages
Global
From €5620EUR$6,360USD£4,951GBP
€7025EUR$7,950USD£6,189GBP
- Report
- June 2024
- 200 Pages
Global
From €5620EUR$6,360USD£4,951GBP
€7025EUR$7,950USD£6,189GBP
- Clinical Trials
- April 2024
- 390 Pages
Global
From €2209EUR$2,500USD£1,946GBP
- Report
- March 2024
- 132 Pages
Global
From €840EUR$950USD£740GBP
- Report
- February 2024
- 23 Pages
Global
€15155EUR$17,150USD£13,352GBP
- Report
- February 2024
- 29 Pages
Global
€15155EUR$17,150USD£13,352GBP
- Report
- January 2024
- 172 Pages
Global
From €1935EUR$2,190USD£1,705GBP
- Report
- January 2024
- 95 Pages
United States
€3093EUR$3,500USD£2,725GBP
- Report
- January 2024
- 39 Pages
United States

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups.
The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products.
Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more